statements

Sunil Healthcare Ltd.

BSE: 537253

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

72.25+1.1 (+1.55%)

24 Jul, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Sunil Healthcare Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	43.43	46.13	61.66	72.64	81.62	108.48	91.33	80.88	70.02	90.29	119.16	110.49	90.19	83.42	87.72
Cost of Operating Revenue	22.44	23.68	25.52	37.26	39.14	55.79	40.82	34.17	34.71	48.82	54.76	54.22	52.47	43.02	39.22
Gross Profit	20.99	22.45	36.14	35.37	42.48	52.69	50.52	46.71	35.31	41.48	64.40	56.27	37.73	40.40	48.50
Gross Margin	48.3	48.7	58.6	48.7	52.0	48.6	55.3	57.8	50.4	45.9	54.0	50.9	41.8	48.4	55.3
Total Operating Expenses	39.05	42.67	54.44	64.97	71.11	97.67	82.22	75.29	80.47	91.06	108.08	101.34	92.02	77.83	81.39
Operating Profit	4.38	3.46	7.22	7.67	10.52	10.82	9.12	5.59	-10.45	-0.76	11.08	9.15	-1.83	5.59	6.33
Operating Margin	10.1	7.5	11.7	10.6	12.9	10.0	10.0	6.9	-14.9	-0.8	9.3	8.3	-2.0	6.7	7.2
Financing Income/(Expense) - Net	-1.95	-2.61	-2.48	-2.46	-3.81	-4.18	-5.03	-6.58	-5.75	-4.99	-2.57	-4.17	-5.78	-8.04	-6.16
Profit before Taxes	3.28	2.19	5.12	6.15	8.03	7.89	6.31	-0.81	-3.00	-0.55	9.26	9.48	-2.56	-1.22	2.23
Income Taxes	1.11	0.74	1.84	2.17	2.81	2.86	1.82	-0.18	-0.63	0.08	2.84	2.80	-0.77	0.20	-1.78
Profit after Tax	2.17	1.44	3.28	3.98	5.23	5.03	4.49	-0.69	-4.96	-0.64	6.42	6.68	-1.78	-1.42	4.01
PAT Margin	5.0	3.1	5.3	5.5	6.4	4.6	4.9	-0.9	-7.1	-0.7	5.4	6.0	-2.0	-1.7	4.6
EPS - Basic - ex Extraordinary Items	2.24	1.41	3.20	3.88	5.10	4.91	4.38	-0.60	-2.31	-0.62	6.26	6.52	-1.74	-1.38	3.91
EPS - Diluted - ex Extraordinary Items	2.24	1.41	3.20	3.88	5.10	4.91	4.38	-0.60	-2.31	-0.62	6.26	6.52	-1.74	-1.38	3.91
EBIT	4.38	3.46	7.22	7.67	10.52	10.82	9.12	5.59	-10.45	-0.76	11.08	9.15	-1.83	5.59	6.33
EBITDA	7.61	7.30	11.32	13.01	14.34	15.15	13.90	11.33	-4.33	5.35	17.39	16.17	4.26	11.94	12.76
EBITDA Margin	17.5	15.8	18.4	17.9	17.6	14.0	15.2	14.0	-6.2	5.9	14.6	14.6	4.7	14.3	14.5

Balance Sheet

Abridged

Understanding Balance Sheet

Sunil Healthcare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	C 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR	PRESS
Total Current Assets	20.92	24.14	27.76	33.36	44.17	56.94	69.14	65.47	59.12	48.51	34.81	48.11	62.49	65.11	73.86
Long-Term Investments	-	-	-	-	-	-	0.10	0.11	0.11	2.00	2.03	1.99	2.13	1.50	1.89
Property Plant & Equipment - Net	22.83	28.63	27.06	27.90	40.83	59.51	70.83	70.97	69.73	69.61	71.55	70.32	92.73	94.13	87.60
Total Non-Current Assets	25.52	29.20	27.89	30.18	41.62	61.90	73.06	72.26	71.11	72.05	74.88	72.68	96.01	96.83	90.65
Total Assets	46.44	53.34	55.66	63.54	85.79	118.84	142.20	137.73	130.23	120.56	109.69	120.79	158.50	161.94	164.51
Total Current Liabilities	22.86	26.15	25.97	29.50	41.54	56.48	68.42	74.06	66.26	53.05	39.81	45.48	57.30	62.60	66.34
Long Term Debt	2.44	4.33	3.80	5.70	9.16	12.78	18.30	9.70	12.03	16.14	11.04	9.81	20.27	19.40	15.51
Total Non-Current Liabilities	5.14	7.33	6.57	8.17	13.19	19.45	26.35	16.89	19.36	23.79	19.92	19.31	32.98	32.27	28.56
Total Liabilities	28.01	33.48	32.53	37.67	54.73	75.93	94.77	90.96	85.63	76.85	59.74	64.79	90.28	94.88	94.90
Total Shareholders' Equity	18.43	19.86	23.13	25.87	31.06	42.91	47.43	46.77	44.60	43.72	49.95	56.00	68.22	67.07	69.60
Total Equity	18.43	19.86	23.13	25.87	31.06	42.91	47.43	46.77	44.60	43.72	49.95	56.00	68.22	67.07	69.60
Total Liabilities & Equity	46.44	53.34	55.66	63.54	85.79	118.84	142.20	137.73	130.23	120.56	109.69	120.79	158.50	161.94	164.51

Cash Flow

Abridged

Understanding Cash Flow Statement

Sunil Healthcare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	5.55	4.12	8.49	6.89	10.01	11.34	9.27	4.82	-4.07	2.14	18.18	11.67	2.12	5.66	10.78
Working Capital - Increase/(Decrease)	-3.94	-2.39	-2.67	-3.38	-5.82	-4.47	-8.55	3.56	2.16	9.20	1.18	-8.01	-22.66	-0.08	5.59
Net CF from Operating Activities	1.61	1.73	5.81	3.51	4.19	6.87	0.72	8.38	-1.92	11.35	19.36	3.66	-20.54	5.58	16.37
Capital Expenditures - Net	4.08	7.53	2.95	7.81	14.46	12.94	15.61	5.51	0.69	6.71	9.02	3.48	10.18	9.00	3.55
Net CF from Investing Activities	-4.17	-7.71	-2.84	-8.59	-15.03	-12.96	-17.29	-3.08	-2.84	-11.71	-4.38	-3.60	-10.50	-8.00	-3.03
Debt - LT & ST - Issuance/(Retirement) - Total	2.69	5.70	-2.51	5.23	11.89	6.26	15.90	-5.01	-6.66	-0.42	-15.26	0.26	30.54	2.37	-13.30
Net Cash Flow from Financing Activities	2.68	5.70	-2.51	5.23	11.89	6.26	15.90	-5.01	4.99	-0.42	-15.26	0.26	30.54	2.37	-13.30
Free Cash Flow to Equity	0.22	-0.10	0.36	0.94	1.62	0.19	1.00	-2.14	-9.27	4.22	-4.92	0.44	-0.18	-1.05	-0.48
Free Operating CF net dividend	-2.47	-5.85	2.76	-4.35	-10.28	-6.43	-14.90	2.79	-2.73	4.51	10.32	-0.54	-31.01	-3.85	12.78
Free Operating CF	-2.47	-5.85	2.76	-4.35	-10.28	-6.43	-14.90	2.79	-2.73	4.51	10.32	-0.54	-31.01	-3.85	12.78

Business Segment Analysis

Sunil Healthcare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Sunil Healthcare Ltd.

Regional Segment Analysis

Sunil Healthcare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Sunil Healthcare Ltd.

Historical Segment Analysis

Track how Sunil Healthcare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Sunil Healthcare Ltd.

Frequently Asked Questions

What is the revenue of Sunil Healthcare Ltd.?

The latest trailing twelve month revenue of Sunil Healthcare Ltd. is ₹ 87.72 Cr, reflecting a 1-year growth of 5.15% and a 3-year CAGR of -7.40%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Sunil Healthcare Ltd.?

The latest trailing twelve month net profit (PAT) of Sunil Healthcare Ltd. is ₹ 4.01 Cr, with a 3-year earnings CAGR of -15.65%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Sunil Healthcare Ltd.?

The trailing twelve month EBITDA of Sunil Healthcare Ltd. is approximately ₹ 6.33 Cr (based on an operating margin of 7.21%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Sunil Healthcare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Sunil Healthcare Ltd. is 3.91. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Sunil Healthcare Ltd.?

The debt-to-equity ratio of Sunil Healthcare Ltd. stands at 0.80. The interest coverage ratio is 1.03x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Sunil Healthcare Ltd.?

The estimated book value per share of Sunil Healthcare Ltd. is 67.87 (derived from a P/B ratio of 1.06 and market price of ₹ 72.25), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Sunil Healthcare Ltd.?

The trailing twelve month operating cash flow of Sunil Healthcare Ltd. is ₹ 16.37 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Sunil Healthcare Ltd. report consolidated or standalone financials?

Sunil Healthcare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.